Compare · KMTS vs RMD
KMTS vs RMD
Side-by-side comparison of Kestra Medical Technologies Ltd. (KMTS) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KMTS and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $28.08B, about 24.7x KMTS ($1.13B).
- Over the past year, KMTS is down 0.7% and RMD is down 22.9% - KMTS leads by 22.2 points.
- RMD has been more active in the news (7 items in the past 4 weeks vs 6 for KMTS).
- RMD has more recent analyst coverage (25 ratings vs 7 for KMTS).
- Company
- Kestra Medical Technologies Ltd.
- ResMed Inc.
- Price
- $19.45-2.43%
- $193.56-1.72%
- Market cap
- $1.13B
- $28.08B
- 1M return
- -11.23%
- -2.69%
- 1Y return
- -0.71%
- -22.93%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 6
- 7
- Recent ratings
- 7
- 25
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Latest KMTS
- Chief Business Officer Moran Timothy P. was granted 22,704 shares, increasing direct ownership by 116% to 42,261 units (SEC Form 4)
- Chief Commercial Officer Ford Alfred J Jr was granted 25,227 shares, increasing direct ownership by 51% to 74,639 units (SEC Form 4)
- Chief Financial Officer Mahboob Vaseem was granted 25,227 shares, increasing direct ownership by 59% to 67,961 units (SEC Form 4)
- Officer Umberger Traci S was granted 25,227 shares, increasing direct ownership by 18% to 161,860 units (SEC Form 4)
- Officer Webster Brian Daniel was granted 75,681 shares, increasing direct ownership by 23% to 410,467 units (SEC Form 4)
- Officer Webster Brian Daniel sold $314,329 worth of shares (15,000 units at $20.96) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 334,786 units (SEC Form 4)
- Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
- Kestra Showcases Accelerated Innovation at HRS 2026
- SEC Form 4 filed by Webster Brian Daniel
- Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
Latest RMD
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $968,064 worth of ResMed Common Stock (4,991 units at $193.96) as part of a pre-agreed trading plan, increasing direct ownership by 0.01% to 466,256 units (SEC Form 4)
- Global General Counsel Rider Michael J covered exercise/tax liability with 269 units of ResMed Common Stock, decreasing direct ownership by 3% to 9,488 units (SEC Form 4) (tax withholding)
- Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
- Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
- SEC Form SD filed by ResMed Inc.
- Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
- Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,037,233 worth of ResMed Common Stock (4,991 units at $207.82) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 3 filed by new insider Bloomer Aaron
- SEC Form 4 filed by Chief Financial Officer Sandercock Brett